Actinomycin D: Chemotherapy Drug Uses, Dosage, and Side Effects

Summary of Key Points

Actinomycin D is a chemotherapy drug used to treat various cancers, including Wilms’ tumor, rhabdomyosarcoma, and testicular cancer. It works by slowing or stopping the growth of cancer cells. Actinomycin D is typically administered via injection by a healthcare provider. Like all chemotherapy drugs, it can cause side effects, so it’s important to discuss any concerns with your doctor or schedule a telemedicine appointment with one of our providers.

Names of Medication

US Brand Name: Cosmegen

(Generic name: Actinomycin D)

The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer. In this case, Actinomycin D is the generic name.

Pharmacologic Category

Actinomycin D falls under the following pharmacologic categories:

1. Antineoplastic Agent
2. Antitumor Antibiotic

Dosing Information for Actinomycin D

Actinomycin D is used to treat several types of cancer. The dose and duration of treatment depend on the specific condition. Always consult your healthcare provider before adjusting your dose or starting a new treatment plan. If needed, you can schedule a telemedicine appointment with us.

1. Wilms’ Tumor: 15 mcg/kg/day for 5 days, repeated every 3 to 6 weeks.
2. Rhabdomyosarcoma: 15 mcg/kg/day for 5 days, repeated every 3 to 6 weeks.
3. Choriocarcinoma: 12 mcg/kg/day for 5 days, repeated every 2 weeks.
4. Testicular Cancer: 1,000 mcg/m² on days 1 and 2 of a 21-day cycle.
5. Ewing’s Sarcoma: 15 mcg/kg/day for 5 days, repeated every 3 to 6 weeks.
6. Neuroblastoma: 15 mcg/kg/day for 5 days, repeated every 3 to 6 weeks.
7. Gestational Trophoblastic Disease: 12 mcg/kg/day for 5 days, repeated every 2 weeks.
8. Melanoma: Dosing is individualized based on the patient’s condition and response to treatment.
9. Soft Tissue Sarcoma: 15 mcg/kg/day for 5 days, repeated every 3 to 6 weeks.
10. Leukemia: Dosing is individualized based on the patient’s condition and response to treatment.

Dosage Forms and Strengths

Actinomycin D is available in the following dosage form:

1. Injection: 500 mcg (0.5 mg) vial

Administration Instructions for Actinomycin D

Actinomycin D is administered by a healthcare professional, typically through an intravenous (IV) injection. It is crucial to follow your healthcare provider’s instructions carefully. If you have any questions about your treatment or need assistance, you can book a telemedicine appointment with one of our providers.

Adverse Reactions and Side Effects of Actinomycin D

Like all chemotherapy drugs, Actinomycin D can cause side effects. Some are common, while others are rare but serious. If you experience any side effects, contact your healthcare provider immediately.

Common Side Effects

1. Nausea and Vomiting: Feeling sick or vomiting is common with chemotherapy drugs.
2. Fatigue: You may feel unusually tired or weak during treatment.
3. Hair Loss: Temporary hair loss may occur.

Serious Side Effects

1. Bone Marrow Suppression: This can lead to a decrease in blood cells, increasing the risk of infection, bleeding, or anemia.
2. Liver Toxicity: Actinomycin D can cause liver damage, which may be detected through blood tests.
3. Severe Skin Reactions: In some cases, Actinomycin D can cause painful skin reactions, especially if the drug leaks outside the vein during injection.

Contraindications for Actinomycin D

A contraindication is a specific situation or condition where a medication should not be used because it may cause harm. If you have any of the following conditions, Actinomycin D may not be safe for you. Always consult with your healthcare provider, and our telemedicine team is available to help assess your situation.

1. Hypersensitivity to Actinomycin D: If you have a known allergy to Actinomycin D or any of its components, taking this medication could trigger a severe allergic reaction, including symptoms like rash, difficulty breathing, or swelling.
2. Severe Bone Marrow Suppression: Actinomycin D can further suppress bone marrow function, which produces blood cells. If you already have low blood cell counts, this medication could worsen your condition, increasing the risk of infections, anemia, or bleeding.
3. Active Infections: Since Actinomycin D weakens the immune system, it is contraindicated in patients with active infections. Taking it could make it harder for your body to fight infections, leading to more severe complications.
4. Liver or Kidney Disease: Actinomycin D is processed by the liver and kidneys. If you have significant liver or kidney impairment, the medication may not be cleared from your body properly, leading to toxic levels and increased side effects.

Drug-to-Drug Interactions with Actinomycin D

Actinomycin D can interact with other medications, increasing the risk of side effects or reducing treatment effectiveness. Inform your healthcare provider of all medications you are taking, including over-the-counter drugs and supplements. Below are some common medications that may interact with Actinomycin D:

1. Warfarin (Coumadin): Actinomycin D may increase the risk of bleeding when taken with blood thinners like warfarin.
2. Phenytoin (Dilantin): This anti-seizure medication may have reduced effectiveness when taken with Actinomycin D, potentially increasing the risk of seizures.
3. Live Vaccines: Since Actinomycin D suppresses the immune system, live vaccines (such as the MMR vaccine) may not work as intended and could lead to infections.
4. Cisplatin (Platinol): When used together with Actinomycin D, there is an increased risk of kidney damage and bone marrow suppression.

Actinomycin D in Pregnancy

Is it safe to take Actinomycin D during pregnancy?

Actinomycin D, a chemotherapy drug, is not considered safe for use during pregnancy. It is classified as a Category D medication, meaning it poses potential risks to the fetus based on human studies. Actinomycin D has been associated with birth defects and miscarriage. If you are pregnant or planning to become pregnant, it is crucial to consult your healthcare provider about alternative cancer treatments. If you are already taking Actinomycin D and discover you are pregnant, contact your healthcare provider immediately. Our telemedicine team is available to help you explore safer treatment options for your condition.

Actinomycin D while Breastfeeding

Is it safe to take Actinomycin D while breastfeeding?

No, Actinomycin D is not recommended for use while breastfeeding. This chemotherapy drug can pass into breast milk and may harm a nursing infant. If you are breastfeeding and require Actinomycin D treatment, your healthcare provider may advise you to stop breastfeeding or consider an alternative chemotherapy drug. It is important to discuss your options with your provider, and our telemedicine team is here to assist you in making the best decision for both you and your baby.

Estimated Cost of Actinomycin D

The cost of Actinomycin D can vary depending on the pharmacy and your location. With a GoodRx coupon, the estimated cost for a 30-day supply without insurance typically ranges from $1,500 to $2,000. For the most accurate pricing, check with your local pharmacy. Additionally, you may want to explore discount programs or patient assistance services to help manage the cost of your treatment.

Possible Alternatives to Actinomycin D

If Actinomycin D is not suitable for you, there may be alternative treatments available depending on your specific condition. Always consult your healthcare provider before making any changes to your treatment plan. Our telemedicine team is here to help you explore these alternatives.

Wilms Tumor

Potential alternatives include surgery, radiation therapy, or other chemotherapy agents such as vincristine or doxorubicin. Discuss these options with your healthcare provider to determine the best course of action.

Rhabdomyosarcoma

Treatment options may involve a combination of surgery, radiation, and other chemotherapy drugs like vincristine or cyclophosphamide.

Choriocarcinoma

Alternative chemotherapy agents such as methotrexate or etoposide may be considered. In some cases, surgery may also be an option.

Testicular Cancer

Cisplatin-based chemotherapy, surgery, or radiation therapy may serve as alternatives to Actinomycin D for treating testicular cancer.

Ewing’s Sarcoma

Other chemotherapy agents, such as ifosfamide or etoposide, along with surgery and radiation, may be considered as alternative treatments.

Neuroblastoma

Treatment alternatives may include surgery, radiation, or other chemotherapy drugs like cyclophosphamide or topotecan.

Gestational Trophoblastic Disease

Depending on the specific type and stage of the disease, methotrexate or dactinomycin may be used as alternative treatments.

Melanoma

Immunotherapy or targeted therapy drugs, such as pembrolizumab or nivolumab, may be considered as alternatives to Actinomycin D for melanoma treatment.

Soft Tissue Sarcoma

Alternatives may include surgery, radiation, or chemotherapy agents like doxorubicin or ifosfamide.

Leukemia

Depending on the type of leukemia, alternative treatments may include other chemotherapy agents, targeted therapies, or bone marrow transplantation.

Recent Updates on Actinomycin D Research

Recent research on Actinomycin D has focused on improving its effectiveness in treating certain cancers while minimizing its side effects. Ongoing studies are exploring its use in combination with newer targeted therapies and immunotherapies to enhance outcomes for patients with challenging cancers, such as soft tissue sarcoma and neuroblastoma. Researchers are also investigating ways to reduce the drug’s toxicity, particularly its impact on bone marrow suppression and kidney function. While these studies are still in the early stages, they offer hope for more effective and safer cancer treatments. Be sure to discuss any new treatment options with your healthcare provider, and our telemedicine team can help you stay informed about the latest advancements in cancer care.

James Kingsley

Learn More